BioNTech SE's turn toward oncology treatments has the potential to tap multi-billion-dollar markets in the future. Find out ...

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that Ryan Richardson will step down as Chief Strategy Officer in the Management Board of BioNTech on September 30, 2025, and as ...

BioNTech is losing its chief strategy officer, with Ryan Richardson set to leave the company at the end of September to ...

There has been a rise in deals and investment to grow US manufacturing operations, due to impending tariffs on the sector.

The 12-month price targets, analyzed by analysts, offer insights with an average target of $133.42, a high estimate of $155.00, and a low estimate of $110.00. A negative shift in sentiment is evident ...

Turkish scientists say that Pfizer's COVID-19 vaccine can increase the risk of eye damage, causing vision loss. A new study ...

A recent Turkish study published in Ophthalmic Epidemiology suggests the Pfizer-BioNTech COVID-19 vaccine may cause subtle ...

The results revealed that taking both doses of Pfizer's COVID-19 vaccine led to fewer endothelial cells in the eye and ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

J.P. Morgan analyst Jessica Fye maintained a Hold rating on Alkermes today and set a price target of $34.00. The company’s shares closed yesterday at $29.20. Elevate Your Invest ...

A new scientific study has found that Pfizer’s COVID-19 vaccine may cause temporary changes in the eyes’ corneal structure, ...